ARTICLE
19 December 2017

Insurance Predictions 2018: Nanomaterials – The Next Wave Of Legacy Claims?

CC
Clyde & Co

Contributor

Clyde & Co  logo
Clyde & Co is a leading, sector-focused global law firm with 415 partners, 2200 legal professionals and 3800 staff in over 50 offices and associated offices on six continents. The firm specialises in the sectors that move, build and power our connected world and the insurance that underpins it, namely: transport, infrastructure, energy, trade & commodities and insurance. With a strong focus on developed and emerging markets, the firm is one of the fastest growing law firms in the world with ambitious plans for further growth.
‘The new asbestos' is a term that has been applied to all manner of emerging risks over recent years, many without justification, but nanotechnology may be shaping up to be deserving of the epithet.
United Kingdom Insurance

'The new asbestos' is a term that has been applied to all manner of emerging risks over recent years, many without justification, but nanotechnology may be shaping up to be deserving of the epithet.

Studies have questioned the safety of this developing technology, despite being heralded as the next miracle material. The parallels with asbestos are there to be seen: recent findings reveal that certain nanotubes could pose the same cancer risk as the infamous toxic mineral.

Human exposure to nanoparticles is increasing. The technology is routinely incorporated into the entire food processing chain, as well as products such as paint, sunscreen and vehicles.  Within the next few years, the nanotechnology industry will employ as many as two million people worldwide, creating a potentially massive cohort of future claimants.

Thanks to the recent studies, this improved understanding should inform manufacturers and regulators about safer options and will hopefully contribute to a 'safe by design' approach to manufacture.  Insurers must continue to monitor these developments in order to understand the risks from both an underwriting and claims perspective.

You can read the rest of our insurance predictions  here. 

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More